Research Article
A2ML1 Inhibits Esophageal Squamous Cell Carcinoma Progression and Serves as a Novel Prognostic Biomarker
Table 2
Cox proportional hazard regression analyses for overall survival.
| Factors | Univariate analysis | Multivariate analysis | HR (95% CI) | value | HR (95% CI) | value |
| Age | <60 years | | | | | ≥60 years | 1.045 (0.591–1.848) | 0.8808 | | |
| Sex | Female | | | | | Male | 0.848 (0.512–1.404) | 0.5217 | | |
| T stage | T1-2 | | | | | T3-4 | 1.984 (1.222–3.221) | 0.0056 | 1.376 (0.819–2.312) | 0.2285 |
| N stage | N0 | | | | | N+ | 1.42 (0.888–2.271) | 0.1434 | 1.377 (0.836–2.27) | 0.209 |
| Differentiation | Well | | | | | Moderate-poor | 1.377 (0.837–2.264) | 0.2076 | 1.349 (0.795–2.288) | 0.2669 |
| A2ML1 protein level | Low | | | | | High | 0.232 (0.137–0.392) | <0.0001 | 0.252 (0.146–0.436) | <0.0001 |
|
|
; ; A2ML1, α2-macroglobulin-like 1; CI, confidence interval; HR, hazard ratio. |